Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls

Journal of Medical Virology

Volumn 56, Issue 3, 1998, Pages 210-216

  Cubie, Heather A ^a   Plumstead, Michael ^b   Zhang, Wei ^b   De Jesus, Orlando ^b   Duncan, Linda A ^a   Stanley, Margaret A ^b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ELISA; HPV; Virus like particles

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; BACULOVIRUS; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; SCHOOL CHILD; VIRION; VIRUS PARTICLE; WART VIRUS;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPRODUCIBILITY OF RESULTS; SEROEPIDEMIOLOGIC STUDIES; TUMOR VIRUS INFECTIONS; VIRION;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; HUMAN POLIOVIRUS 1; UNIDENTIFIED BACULOVIRUS;

EID: 0031720152     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199811)56:3<210::AID-JMV6>3.0.CO;2-A     Document Type: Article

References (40)

1. Andersson-Ellstrom A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, Milsom I (1996): Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sexually Transmitted Diseases 23:234-238.
2. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248-254.
3. Carter JJ, Galloway DA (1997): Humoral immune response to human papillomavirus infection. Clinics in Dermatology 15:249-259.
4. Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee S-K, Kuypers J, Kiviat N, Galloway DA (1996): The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. Journal of Infectious Diseases 174:927-936.
5. Cason J, Kaye JN, Jewers RJ, Kambo PK, Bible JM, Kell B, Shergill B, Pakarian F, Raju KS, Best JM (1995): Perinatal infection of human papillomavirus types 16/18 in infants. Journal of Medical Virology 47:209-218.
6. Cason J, Kaye JN, Best JM (19961: Evidence for the transmission of human genital papillomavirusesby non-sexual routes. In Lacey C (ed): "Papillomavirus Reviews: Current Research on Papillomaviruses." Leeds: Leeds Medical Information, pp 281-290.
7. Christensen ND, Hopfl R, Di Angelo SL, Cladel NM, Patrick SD, Welsh PA, Budgeon LR, Reed CA, Kreider JW (1994): Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies Journal of General Virology 75:2271-2276.
8. Coleman N, Birley H, Renton MA, Hanna NF, Ryait BK, Weber J, Taylor Robinson D, Stanley MA (1994): Immunological events in regressing warts. American Journal of Clinical Pathology 102: 768-774.
9. Cubie HA (1972): Serological studies in a student population prone to infection with human papilloma virus. Journal of Hygiene 70:677-690.
10. Cubie HA, Burns SM, Hargreaves FD, Edmond E, Zealley H (1985): Rubella: Immunity and vaccination in schoolgirls. British Medical Journal [Clinical Research Ed.] 290:1927-1928.
11. De Gruijl TD, Bontkes HJ, Walboomers JM, Schiller JT, Stukart MJ, Groot BS, Chabaud MM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ (1997): Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. JNCI 89:630-638.
12. De Villiers EM (1994): Human pathogenic papillomavirus types: An update. Current Topics in Microbiology and Immunology 186:1-12.
13. Dillner J, Wiklund F, Lenner P, Eklund C, Fredriksson-Shanazarian V, Schiller JT, Hibma M, Hallmans G, Stendahl U (1995): Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cancer. International Journal of Cancer 60:377-382.
14. Fredericks BD, Balkin A, Daniel HW, Schonrock J, Ward B, Frazer IH (1993): Transmission of human papillomavirus from mother to child. Australian and New Zealand Journal of Obstetrics and Gynaecology 33:30-32.
15. Hagensee M, Yaegashi N, Galloway DA (1993): Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. Journal of Virology 67:315-322.
16. Heim K, Christensen ND, Hoepfl R, Wartusch B, Pinzger G, Zeimet A, Baumgartner P, Kreider JW, Dapunt O (1995): Serum IgG, IgM and IgA reactivity to human papillomavirus types 11 and 6 virus like particles in different gynaecologic patient groups. Journal of Infectious Diseases 172:395-402.
17. IARC Working Group (1995): Human papillomaviruses. Meeting of IARC Working Group on 6-13 June 1995. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 64:9-378.
18. Kaye JN, Cason J, Pakarian FB, Jewers RJ, Kell B, Bible JM, Raju KS, Best JM (1994): Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child. Journal of Medical Virology 44:415-421.
19. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT (1992): Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences of the United States of America 89: 12180-12184.
20. Marais D, Rose RC, Williamson A-M (1997): Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia, and blood donors from South Africa. Journal of Medical Virology 51:126-131.
21. McLean C, Churcher M, Meinke J, Smith G, Higgins G, Stanley M (1990): Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. Journal of Clinical Pathology 43:488-492.
22. Nonnenmacher B, Hubbert N, Kirnbauer R, Shah KV, Munoz N, Bosch FX, de Sanjose S, Viscidi R, Lowy DR, Schiller J (1995): Serological response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV 16 DNA-positive invasive cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. Journal of Infectious Diseases 172:19-24.
23. Pakarian FB, Kaye JM, Cason J, Kell B, Jewers RJ, Raju KS, Best JM (1994): Cancer associated human papillomaviruses: Perinatal transmission and persistence. British Journal of Obstetrics and Gynaecology 101:514-517.
24. Puranen M, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S (1996): Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. American Journal of Obstetrics and Gynecology 174: 694-699.
25. Puranen MH, Yliskoski MH, Saarikoski SV, Syrjanen KJ, Syrjanen SM (1997): Exposure of an infant to cervical human papillomavirus infection of the mother is common. American Journal of Obstetrics and Gynecology 176:1039-1045.
26. Rose RC, Reichman RC, Bonnez W (1994): Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralising antibodies and detect HPV-specific antibodies in human sera. Journal of General Virology 75:2075-2079.
27. Schiller JT, Roden RBS (1996): Papillomavirus-like particles: Basic and applied studies. In Lacey C (ed): "Papillomavirus Reviews: Current Research on Papillomaviruses." Leeds: Leeds Medical Information, pp 101-111.
28. Sedlacek TV, Lindheim S, Eder C, Hasty L, Woodland M, Ludomirsky A, Rando RF (1989): Mechanism for human papillomavirus transmission at birth. American Journal of Obstetrics and Gynecology 161:55-59.
29. Selvakumar R, Ahmed R, Wettstein FO (1995): Tumor regression is associated with a specific immune response to the E2 protein of cotton tail rabbit papilloroavirus. Journal of Virology 69:602-605.
30. Stanley MA (1997): Genital human papillomaviruses - Prospects for vaccination. Current Opinion in Infectious Disease 10:55-61.
31. Steele JC, Gallimore PH (1990): Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. Virology 174:388-398.
32. Suzich JA, Ghim SJ, Palmer Hill FJ, White WI, Tamura JK, Bell JA, Newsome JA, Jenson AB, Schlegel R (1995): Systemic immunisation with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas Proceedings of the National Academy of Sciences of the United States of America 92:11553-11557.
33. Tseng TJ, Liang CC, Soong YK, Pao CC (1998): Perinatal transmission of human papillomavirus in infants: Relationship between infection and mode of delivery. Obstetrics and Gynecology 91:92-96.
34. Van Ranst M, Tachezy R, Burk RD (1996): Human papillomaviruses: A never ending story? In Lacey C (ed): "Papillomavirus Reviews: Current Research on Papillomaviruses." Leeds: LMI, pp 1-20.
35. Wang Z, Konya J, Avall-Lundkvist E, Sapp M, Dillner J, Dillner L (1997): Human papillomavirus antibody responses among patients with incident cervical carcinoma. Journal of Medical Virology 52: 436-440.
36. Westgard JO, Barry PL, Hunt MR, Groth T (1981): A multi-rule Shewhart chart for quality control in clinical chemistry. Clinical Chemistry 27:493-501.
37. Wideroff L, Schiffman MH, Hoover R, Tarone RE, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME, Buckland J, Lowy D, Schiller J (1996): Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and -negative women. Journal of Infectious Diseases 174:937-943.
38. Wikstrom A, Eklund C, von Krogh G, Lindbrink P, Dillner J (1992): Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata. Journal of Clinical Microbiology 30:1795-1800.
39. Zhang W, Carmichael J, Ferguson J, Inglis S, Ashrafian H, Stanley M (1998): Expression of human papillomavirus type 16 L1 Escherichia coli: Denaturation, renaturation and self-assembly of virus-like particles in vitro. Virology 243:423-431.
40. Zhou J, Sun XY, Stenzel DJ, Frazer IH (1991): Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185: 251-257.